Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT India 2025

Dissection/Obstructions and vessel reconstruction (focus on side branch loss, distal hemtoma, plaque prolapse, etc)

Presenter: Gary S. Mintz

July 25, 2025

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Industry News

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

May 19, 2016

News Industry News

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

March 22, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

Advertisement

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Dissection/Obstructions and vessel reconstruction (focus on side branch loss, distal hemtoma, plaque prolapse, etc)

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Top News in Coronary Artery Disease: 2018

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

ESC Updates Guidelines for Treating STEMI Patients

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content